The B subunit of Escherichia coli heat-labile enterotoxin enhances CD8+ cytotoxic-T-lymphocyte killing of Epstein-Barr virus-infected cell lines

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 4298-4305

  Ong, Kong Wee ^a,b   Wilson, A Douglas ^a   Hirst, Timothy R ^a   Morgan, Andrew J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b DIVISION OF MEDICAL ONCOLOGY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; CELL NUCLEUS ANTIGEN; ENTEROTOXIN; LATENT MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TUMOR ANTIGEN; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CELL KILLING; CYTOTOXIC T LYMPHOCYTE; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; IMMUNE RESPONSE; LYMPHOBLASTOID CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; BACTERIAL TOXINS; CELL LINE; CELL MEMBRANE; CYSTEINE ENDOPEPTIDASES; CYTOTOXICITY, IMMUNOLOGIC; ENTEROTOXINS; EPITOPES; EPSTEIN-BARR VIRUS INFECTIONS; ESCHERICHIA COLI PROTEINS; G(M1) GANGLIOSIDE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; VIRAL MATRIX PROTEINS;

EID: 0037378586     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.4298-4305.2003     Document Type: Article

References (61)

1. Amin, T., and T. R. Hirst. 1994. Purification of the B-subunit oligomer of Escherichia coli heat-labile enterotoxin by heterologous expression and secretion in a marine vibrio. Protein Expr. Purif. 5:198-204.
2. Aviel, S., G. Winberg, M. Massucci, and A. Ciechanover. 2000. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitinproteasome pathway: targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 275:23491-23499.
3. + T-cell response: lessons from the EBV nuclear antigen EBNA1. J. Immunol. 165:7078-7087.
4. Brooks, P., R. Z. Murray, G. G. Mason, K. B. Hendil, and A. J. Rivett. 2000. Association of immunoproteasomes with the endoplasmic reticulum. Biochem. J. 352(Pt. 3):611-615.
5. Brown, D. A., and E. London. 1998. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol. 14:111-136.
6. Burrows, S. R., J. Gardner, R. Khanna, T. Steward, D. J. Moss, S. Rodda, and A. Suhrbier. 1994. Five new cytotoxic T-cell epitopes identified within Epstein-Barr virus nuclear antigen 3. J. Gen. Virol. 75(Pt. 9):2489-2493.
7. Cao, H., D. Agrawal, N. Kushner, N. Touzjian, M. Essex, and Y. Lu. 2002. Delivery of exogenous protein antigens to major histocompatibility complex class I pathway in cytosol. J. Infect. Dis. 185:244-251.
8. Chapman, A. L., A. B. Rickinson, W. A. Thomas, R. F. Jarrett, J. Crocker, and S. P. Lee. 2001. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy. Cancer Res. 61:6219-6226.
9. Chua, D., J. Huang, B. Zheng, S. Y. Lau, W. Luk, D. L. Kwong, J. S. Sham, D. Moss, K. Y. Yuen, S. W. Im, and M. H. Ng. 2001. Adoptive transfer of autologous Epstein-Barr virus-specific cytotoxic T cells for nasopharyngeal carcinoma. Int. J. Cancer 94:73-80.
10. Clausse, B., K. Fizazi, V. Walczak, C. Tetaud, J. Wiels, T. Tursz, and P. Busson. 1997. High concentration of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228:285-293.
11. de Haan, L., A. R. Hearn, A. J. Rivett, and T. R. Hirst. 2002. Enhanced delivery of exogenous peptides into the class I antigen processing and presentation pathway. Infect. Immun. 70:3249-3258.
12. de Haan, L., and T. R. Hirst. 2002. Bacterial toxins as versatile delivery vehicles. Curr. Opin. Drug Discov. Dev. 5:269-278.
13. Fraser, S. A., A. R. Hearne, H. K. Bone, R. Salmond, A. J. Rivett, N. R. Williams, and T. R. Hirst. 2003. A mutant Escherichia coli heat-labile B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions. Infect. Immun. 71:1527-1537.
14. Fukuta, S., J. L. Magnani, E. M. Twiddy, R. K. Holmes, and V. Ginsburg. 1988. Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb. Infect. Immun. 56:1748-1753.
15. Gahn, B., F. Siller-Lopez, A. D. Pirooz, E. Yvon, S. Gottschalk, R. Longnecker, M. K. Brenner, H. E. Heslop, E. Aguilar-Cordova, and C. M. Rooney. 2001. Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: a potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma. Int. J. Cancer 93:706-713.
16. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403-450.
17. Goletz, T. J., K. R. Klimpel, N. Arora, S. H. Leppla, J. M. Keith, and J. A. Berzofsky. 1997. Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein. Proc. Natl. Acad. Sci. USA 94:12059-12064.
18. Gottschalk, S., H. E. Heslop, and C. M. Roon. 2002. Treatment of Epstein-Barr virus-associated malignancies with specific T cells. Adv. Cancer Res. 84:175-201.
19. Hamel, Y., N. Blake, S. Gabrielsson, T. Haigh, K. Jooss, C. Martinache, S. Caillat-Zucman, A. B. Rickinson, S. Hacein-Bey, A. Fischer, and M. Cavazzana-Calvo. 2002. Adenovirally transduced dendritic cells induce bispecific cytotoxic T lymphocyte responses against adenovirus and cytomegalovirus pp65 or against adenovirus and Epstein-Barr virus EBNA3C protein: a novel approach for immunotherapy. Hum. Gene Ther. 13:855-866.
20. Higuchi, M., K. M. Izumi, and E. Kieff. 2001. Epstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors. Proc. Natl. Acad. Sci. USA 98:4675-4680.
21. Hill, A. B., S. P. Lee, J. S. Haurum, N. Murray, Q. Y. Yao, M. Rowe, N. Signoret, A. B. Rickinson, and A. J. McMichael. 1995. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised. J. Exp. Med. 181:2221-2228.
22. Holmgren, J., P. Fredman, M. Lindblad, A. M. Svennerholm, and L. Sven. nerholm. 1982. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect. Immun. 38:424-433.
23. Ikeda, M., A. Ikeda, L. C. Longan, and R. Longnecker. 2000. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domaincontaining ubiquitin-protein ligases. Virology 268:178-191.
24. Kaykas, A., K. Worringer, and B. Sugden. 2001. CD40 and LMP-1 both signal from lipid rafts but LMP-1 assembles a distinct, more efficient signaling complex. EMBO J. 20:2641-2654.
25. Khanna, R., S. R. Burrows, J. Nicholls, and L. M. Poulsen. 1998. Identification of cytotoxic T-cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 28:451-458.
26. Khanna, R., P. Busson, S. R. Burrows, C. Raffoux, D. J. Moss, J. M. Nicholls, and L. Cooper. 1998. Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells. Cancer Res. 58:310-314.
27. + T-cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway. J. Exp. Med. 194:1053-1068.
28. Lee, S. P., A. T. Chan, S. T. Cheung, W. A. Thomas, D. CroomCarter, C. W. Dawson, C. H. Tsai, S. F. Leung, P. J. Johnson, and D. P. Huang, 2000. CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J. Immunol. 165:573-582.
29. Lee, S. P., W. A. Thomas, R. J. Murray, F. Khanim, S. Kaur, L. S. Young, M. Rowe, M. Kurilla, and A. B. Rickinson. 1993. HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J. Virol. 67:7428-7435.
30. Lee, S. P., R. J. Tierney, W. A. Thomas, J. M. Brooks, and A. B. Rickinson. 1997. Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy. J. Immunol. 158:3325-3334.
31. Lencer, W. I., T. R. Hirst, and R. K. Holmes. 1999. Membrane traffic and the cellular uptake of cholera toxin. Biochim. Biophys. Acta 1450:177-190.
32. Levitskaya, J., M. Coram, V. Levitsky, S. Imreh, P. M. Steigerwald-Mullen, G. Klein, M. G. Kurilla, and M. G. Masucci. 1995. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 375:685-688.
33. Levitskaya, J., A. Sharipo, A. Leonchiks, A. Clechanover, and M. G. Masucci. 1997. Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616-12621.
34. Levitsky, V., Q. J. Zhang, J. Levitskaya, and M. G. Masucci. 1996. The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4. J. Exp. Med. 183:915-926.
35. Loregian, A., E. Papini, B. Satin, H. S. Marsden, T. R. Hirst, and G. Palu. 1999. Intranuclear delivery of an antiviral peptide mediated by the B subunit of Escherichia coli heat-labile enterotoxin. Proc. Natl. Acad. Sci. USA 96:5221-5226.
36. Marcello, A., A. Loregian, A. Cross, H. Marsden, T. R. Hirst, and G. Palu. 1994. Specific inhibition of herpes virus replication by receptor-mediated entry of an antiviral peptide linked to Escherichia coli enterotoxin B subunit. Proc. Natl. Acad. Sci. USA 91:8994-8998.
37. + T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int. J. Cancer 99:93-99.
38. Millan, J., M. Qaidi, and M. A. Alonso. 2001. Segregation of co-stimulatory components into specific T-cell surface lipid rafts. Eur. J. Immunol. 31:467-473.
39. Millar, D. G., and T. R. Hirst. 2001. Cholera toxin and Escherichia coli enterotoxin B subunits inhibit macrophage-mediated antigen processing and presentation: evidence for antigen persistence in non-acidic recycling endosomal compartments. Cell Microbiol. 3:311-329.
40. Murray, P. G., C. M. Constandinou, J. Crocker, L. S. Young, and R. F. Ambinder. 1998. Analysis of major histocompatibility complex class I, TAP expression, and LMP2 epitope sequence in Epstein-Barr virus-positive Hodgkin's disease. Blood 92:2477-2483.
41. Nashar, T. O., T. R. Hirst, and N. A. Williams. 1997. Modulation of B-cell activation by the B subunit of Escherichia coli enterotoxin: receptor interaction upregulates MHC class II, B7, CD40, CD25 and ICAM-1. Immunology 91:572-578.
42. Nashar, T. O., H. M. Webb, S. Eaglestone, N. A. Williams, and T. R. Hirst. 1996. Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets. Proc. Natl. Acad. Sci. USA 93:226-230.
43. Nichols, B. J., A. K. Kenworthy, R. S. Polishchuk, R. Lodge, T. H. Roberts, K. Hirschberg, R. D. Phair, and J. Lippincott-Schwartz. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153:529-541.
44. Niedobitek, G., N. Meru, and H. J. Delecluse. 2001. Epstein-Barr virus infection and human malignancies. Int. J. Exp. Pathol. 82:149-170.
45. Petrie, R. J., P. P. Schnetkamp, K. D. Patel, M. Awasthi-Kalia, and J. P. Deans. 2000. Transient translocation of the B cell receptor and Src homology 2 domain-containing inositol phosphatase to lipid rafts: evidence toward a role in calcium regulation. J. Immunol. 165:1220-1227.
46. Ranieri, E., W. Herr, A. Gambotto, W. Olson, D. Rowe, P. D. Robbins, L. S. Kierstead, S. C. Watkins, L. Gesualdo, and W. J. Storkus. 1999. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J. Virol. 73:10416-10425.
47. Rees, L., A. Thomas, and P. L. Amlot. 1998. Disappearance of an Epstein-Barr virus-positive post-transplant plasmacytoma with reduction of immunosuppression. Lancet 352:789.
48. Richards, C. M., A. T. Aman, T. R. Hirst, T. J. Hill, and N. A. Williams. 2001. Protective mucosal immunity to ocular herpes simplex virus type 1 infection in mice by using Escherichia coli heat-labile enterotoxin B subunit as an adjuvant. J. Virol. 75:1664-1671.
49. Rickinson, A. B., and D. J. Moss. 1997. Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection. Annu. Rev. Immunol. 15:405-431.
50. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739-779.
51. Roper, K., D. Corbeil, and W. B. Huttner. 2000. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat. Cell Biol. 2:582-592.
52. + T-cell apoptosis induced by Escherichia coli heat-labile enterotoxin B-subunit occurs via a novel pathway involving the NF-κB-dependent caspase activation. Eur. J. Immunol. 32:1737-1747.
53. + T cells recognize EBV antigen but poorly kill autologous EBV-infected B lymphoblasts: immunodominance is elicited by a peptide epitope that is presented at low levels in vitro. J. Immunol. 159:1844-1852.
54. + Hodgkin's disease. Blood 89:1978-1986.
55. + T cells by activating transcription factor c-myc. Infect. Immun. 69:4923-4930.
56. Spiegel, S., S. Kassis, M. Wilchek, and P. H. Fishman. 1984. Direct visualization of redistribution and capping of fluorescent gangliosides on lymphocytes. J. Cell Biol. 99:1575-1581.
57. Su, Z., M. V. Peluso, S. H. Raffegerst, D. J. Schendel, and M. A. Roskrow. 2001. The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgkin disease. Eur. J. Immunol. 31:947-958.
58. Tanner, J. E., and C. Alfieri. 2001. The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis. Transpl. Infect. Dis. 3:60-69.
59. Turcanu, V., T. R. Hirst, and N. A. Williams. 2002. Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit: altered cytokine production and its functional consequences. Immunology 106:316-325.
60. Viola, A., S. Schroeder, Y. Sakakibara, and A. Lanzavecchia. 1999. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283:680-682.
61. Williams, N. A., T. R. Hirst, and T. O. Nashar. 1999. Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol. Today 20:95-101.